Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers

First published: June 2023 DOI: https://doi.org/10.1016/j.lanepe.2023.100621

 

Laymen’s summary:

A comprehensive study conducted in Scandinavia aimed to provide insights into the prevalence, outcomes, treatment, and genetic epidemiology of major depressive disorder (MDD). The study revealed that MDD is highly prevalent in Scandinavia, particularly among females, and is associated with a significant disease burden. The findings showed a substantial heritability of MDD, indicating a genetic component in its development. The study also highlighted differences in diagnostic practices, treatment patterns, and healthcare infrastructure across the Scandinavian countries, which may influence the observed variations in prevalence and treatment density. The research emphasized the importance of addressing the socioeconomic inequalities and mental health burden associated with MDD, not only in Scandinavia but also in other countries. The study called for future research to include diverse populations and expand to low/middle-income countries to identify strategies for reducing health inequities. Overall, the study provided valuable insights into the epidemiological characteristics of MDD, serving as a foundation for further investigations and informing policy decisions related to clinical strategies and interventions

Access the article here.

Published Nov. 29, 2023 4:59 PM - Last modified Nov. 29, 2023 4:59 PM